title: [Thromboembolic disease in orthopedic surgery].
abstract: Thromboembolic complications are frequent after orthopaedic surgery of the limbs. Strategies to minimize these complications go from recognize the risk factors of the patient to introduce new antithrombotic drugs, and including general medical care, regional anaesthesia and early mobilization. Based in epidemiological studies, prophylaxis must be extended 4-6 weeks in total hip and knee arthroplasty and in surgery of the hip fracture.
authors.affiliation: Servicio de Cirugía Ortopédica y Traumatología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España. xgranero.germanstrias@gencat.cat
authors.forename: Javier
authors.initials: J
authors.lastname: Granero Xiberta
authors.forename: José María
authors.initials: JM
authors.lastname: Soler Minoves
authors.forename: Laura
authors.initials: L
authors.lastname: Garcia Nuño
mesh_terms: D000765:Anesthesia, Conduction; D019644:Arthroplasty, Replacement, Hip; D019645:Arthroplasty, Replacement, Knee; D004434:Early Ambulation; D017984:Enoxaparin / Q000008:administration & dosage / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006620:Hip Fractures / Q000601:surgery; D006801:Humans; D007430:Intraoperative Care; D009025:Morpholines / Q000008:administration & dosage / Q000627:therapeutic use; D009985:Orthopedics; D011182:Postoperative Care; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D054556:Venous Thromboembolism / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D017984:Enoxaparin; D005343:Fibrinolytic Agents; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban